LCM
MBOT icon

Lazari Capital Management’s Microbot Medical MBOT Stock Holding History

Lazari Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56K Buy
23,255
+2,000
+9% +$4.47K 0.02% 170
2025
Q4 		$42.5K Hold
21,255
– – 0.01% 162
2025
Q3 		$64.8K Hold
21,255
– – 0.02% 160
2025
Q2 		$53.6K Buy
+21,255
New +$50.9K 0.02% 152

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Lazari Capital Management's MBOT Position: Q1 2026 in Review

Lazari Capital Management increased its Microbot Medical (MBOT) stake by 9.4% in Q1 2026, buying an estimated $4.47K and bringing the position to 23,255 shares worth $56K. The position accounts for 0.02% of the portfolio, ranked #170.

Lazari Capital Management first reported a position in MBOT in Q2 2025 and has held it in 4 quarters since. The position peaked at $64.8K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Lazari Capital Management held 23,255 shares of Microbot Medical worth $56K as of Q1 2026.
  • Lazari Capital Management bought 2,000 Microbot Medical shares in Q1 2026, an estimated $4.47K.
  • Microbot Medical made up 0.02% of Lazari Capital Management's portfolio in Q1 2026, its #170 holding.
  • Lazari Capital Management first reported a position in Microbot Medical in Q2 2025 and has held it in 4 quarters since.
  • Lazari Capital Management's Microbot Medical position peaked at $64.8K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Lazari Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.